Moclobemide

吗氯贝胺

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMoclobemide
Drug Alias Name氯呗胺moclobemidummoclobemida马氯贝胺Aurorix +[10
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMonoamine oxidase inhibitors
TargetsMonoamine oxidase
Therapy Area/IndicationsDepressive Disorder, MajorDepression
Global Approved IndicationsDepressive Disorder, MajorDepression
Approved Indications in ChinaDepression
Original Approved Country/TerritoryCanada
Original Approved Date1992/01/01
Country/TerritoryCanadaUnited KingdomMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsDepressive Disorder, MajorDepression
Inactive IndicationsN/A

Other Information

ATC CodeN06AG02